
IndraLab
Statements
sparser
"The thrombomodulin–fibronectin interaction occurs on tumour blood vessels in murine melanoma suggesting that this interplay may serve as a putative target for antiangiogenic therapy, although an in‐depth understanding of this interaction in healthy tissues would first need to be considered."
sparser
"To elucidate which of the three extracellular domains (lectin-like domain (domain 1; D1), epidermal growth factor (EGF)-like domain (domain 2; D2), and serine-threonine-rich domain (domain 3; D3)) of TM binds fibronectin, we fused the extracellular domain with human IgG Fc protein to create the TMD123-Fc protein ( xref )."
reach
"To elucidate which of the three extracellular domains (lectin like domain (domain 1; D1), epidermal growth factor (EGF)-like domain (domain 2; D2), and serine-threonine-rich domain (domain 3; D3)) of TM binds fibronectin, we fused the extracellular domain with human IgG Fc protein to create the TMD123-Fc protein (XREF_FIG)."
reach
"Since binding of Fn to TM exosomes is mediated through heparin/heparan sulfate, we conclude that a reduction in heparin/heparan sulfate binding proteins likely contributes to decreased Fn binding in exosomes from Dex treated explants.Fn-bound exosomes are reported to mediate a number of cell-matrix interactions including migration and invasion [18, 20], two processes dependent on podosomes/invadopodia and ECM digestion [10]."